Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life

Background Multiple prolonged symptoms observed in patients who recovered from COVID-19 are defined as long COVID. Although diverse phenotypic combinations are possible, they remain unclear. This study aimed to perform a cluster analysis of long COVID in Japan and clarify the association between its...

Full description

Bibliographic Details
Main Authors: Yasunori Sato, Katsunori Masaki, Takanori Asakura, Koichi Fukunaga, Naoto Minematsu, Makoto Ishii, Keita Masuzawa, Ichiro Kawada, Tadashi Manabe, Masahiro Kondo, Shotaro Chubachi, Ho Namkoong, Hideki Terai, Junko Kagyo, Tetsuya Shiomi, Keiko Ohgino, Sohei Nakayama, Yusuke Suzuki, Yohei Funatsu, Hidefumi Koh, Ryo Takemura, Fumimaro Ito, Mizuha Hashiguchi, Takahiro Fukui, Jun Miyata
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/11/1/e002111.full
_version_ 1797296730871431168
author Yasunori Sato
Katsunori Masaki
Takanori Asakura
Koichi Fukunaga
Naoto Minematsu
Makoto Ishii
Keita Masuzawa
Ichiro Kawada
Tadashi Manabe
Masahiro Kondo
Shotaro Chubachi
Ho Namkoong
Hideki Terai
Junko Kagyo
Tetsuya Shiomi
Keiko Ohgino
Sohei Nakayama
Yusuke Suzuki
Yohei Funatsu
Hidefumi Koh
Ryo Takemura
Fumimaro Ito
Mizuha Hashiguchi
Takahiro Fukui
Jun Miyata
author_facet Yasunori Sato
Katsunori Masaki
Takanori Asakura
Koichi Fukunaga
Naoto Minematsu
Makoto Ishii
Keita Masuzawa
Ichiro Kawada
Tadashi Manabe
Masahiro Kondo
Shotaro Chubachi
Ho Namkoong
Hideki Terai
Junko Kagyo
Tetsuya Shiomi
Keiko Ohgino
Sohei Nakayama
Yusuke Suzuki
Yohei Funatsu
Hidefumi Koh
Ryo Takemura
Fumimaro Ito
Mizuha Hashiguchi
Takahiro Fukui
Jun Miyata
author_sort Yasunori Sato
collection DOAJ
description Background Multiple prolonged symptoms observed in patients who recovered from COVID-19 are defined as long COVID. Although diverse phenotypic combinations are possible, they remain unclear. This study aimed to perform a cluster analysis of long COVID in Japan and clarify the association between its characteristics and background factors and quality of life (QOL).Methods This multicentre prospective cohort study collected various symptoms and QOL after COVID-19 from January 2020 to February 2021. This study included 935 patients aged ≥18 years with COVID-19 at 26 participating medical facilities. Hierarchical cluster analysis was performed using 24 long COVID symptom at 3 months after diagnosis.Results Participants were divided into the following five clusters: numerous symptoms across multiple organs (cluster 1, n=54); no or minor symptoms (cluster 2, n=546); taste and olfactory disorders (cluster 3, n=76); fatigue, psychoneurotic symptoms and dyspnoea (low prevalence of cough and sputum) (cluster 4, n=207) and fatigue and dyspnoea (high prevalence of cough and sputum) (cluster 5, n=52). Cluster 1 included elderly patients with severe symptoms, while cluster 3 included young female with mild symptoms. No significant differences were observed in the comorbidities. Cluster 1 showed the most impaired QOL, followed by clusters 4 and 5; these changes as well as the composition of symptoms were observed over 1 year.Conclusions We identified patients with long COVID with diverse characteristics into five clusters. Future analysis of these different pathologies could result in individualised treatment of long COVID.Trial registration number The study protocol is registered at UMIN clinical trials registry (UMIN000042299).
first_indexed 2024-03-07T22:10:04Z
format Article
id doaj.art-5386dc378f2e4ead81e03023b84a1ad8
institution Directory Open Access Journal
issn 2052-4439
language English
last_indexed 2024-03-07T22:10:04Z
publishDate 2024-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Respiratory Research
spelling doaj.art-5386dc378f2e4ead81e03023b84a1ad82024-02-23T16:25:08ZengBMJ Publishing GroupBMJ Open Respiratory Research2052-44392024-02-0111110.1136/bmjresp-2023-002111Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of lifeYasunori Sato0Katsunori Masaki1Takanori Asakura2Koichi Fukunaga3Naoto Minematsu4Makoto Ishii5Keita Masuzawa6Ichiro Kawada7Tadashi Manabe8Masahiro Kondo9Shotaro Chubachi10Ho Namkoong11Hideki Terai12Junko Kagyo13Tetsuya Shiomi14Keiko Ohgino15Sohei Nakayama16Yusuke Suzuki17Yohei Funatsu18Hidefumi Koh19Ryo Takemura20Fumimaro Ito21Mizuha Hashiguchi22Takahiro Fukui23Jun Miyata24Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine Graduate School of Medicine, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine Graduate School of Medicine, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine Graduate School of Medicine, Tokyo, JapanDepartment of Internal Medicine, Hino Municipal Hospital, Tokyo, JapanDepartment of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanDepartment of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, JapanDivision of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, Tokyo, JapanBiostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, JapanDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, JapanDepartment of Internal Medicine, Keiyu Hospital, Kanagawa, JapanDepartment of Internal Medicine, Keiyu Hospital, Kanagawa, JapanDivision of Pulmonary Medicine, Kawasaki Municipal Hospital, Kanagawa, JapanDepartment of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, JapanDepartment of Respiratory Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, JapanDivision of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, Tokyo, JapanDivision of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, Tokyo, JapanClinical and Translational Research Center, Keio University Hospital, Shinjuku, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, JapanDivision of Pulmonary Medicine, Department of Internal Medicine, Tachikawa Hospital, Tokyo, JapanDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, JapanBackground Multiple prolonged symptoms observed in patients who recovered from COVID-19 are defined as long COVID. Although diverse phenotypic combinations are possible, they remain unclear. This study aimed to perform a cluster analysis of long COVID in Japan and clarify the association between its characteristics and background factors and quality of life (QOL).Methods This multicentre prospective cohort study collected various symptoms and QOL after COVID-19 from January 2020 to February 2021. This study included 935 patients aged ≥18 years with COVID-19 at 26 participating medical facilities. Hierarchical cluster analysis was performed using 24 long COVID symptom at 3 months after diagnosis.Results Participants were divided into the following five clusters: numerous symptoms across multiple organs (cluster 1, n=54); no or minor symptoms (cluster 2, n=546); taste and olfactory disorders (cluster 3, n=76); fatigue, psychoneurotic symptoms and dyspnoea (low prevalence of cough and sputum) (cluster 4, n=207) and fatigue and dyspnoea (high prevalence of cough and sputum) (cluster 5, n=52). Cluster 1 included elderly patients with severe symptoms, while cluster 3 included young female with mild symptoms. No significant differences were observed in the comorbidities. Cluster 1 showed the most impaired QOL, followed by clusters 4 and 5; these changes as well as the composition of symptoms were observed over 1 year.Conclusions We identified patients with long COVID with diverse characteristics into five clusters. Future analysis of these different pathologies could result in individualised treatment of long COVID.Trial registration number The study protocol is registered at UMIN clinical trials registry (UMIN000042299).https://bmjopenrespres.bmj.com/content/11/1/e002111.full
spellingShingle Yasunori Sato
Katsunori Masaki
Takanori Asakura
Koichi Fukunaga
Naoto Minematsu
Makoto Ishii
Keita Masuzawa
Ichiro Kawada
Tadashi Manabe
Masahiro Kondo
Shotaro Chubachi
Ho Namkoong
Hideki Terai
Junko Kagyo
Tetsuya Shiomi
Keiko Ohgino
Sohei Nakayama
Yusuke Suzuki
Yohei Funatsu
Hidefumi Koh
Ryo Takemura
Fumimaro Ito
Mizuha Hashiguchi
Takahiro Fukui
Jun Miyata
Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life
BMJ Open Respiratory Research
title Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life
title_full Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life
title_fullStr Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life
title_full_unstemmed Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life
title_short Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life
title_sort cluster analysis of long covid in japan and association of its trajectory of symptoms and quality of life
url https://bmjopenrespres.bmj.com/content/11/1/e002111.full
work_keys_str_mv AT yasunorisato clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT katsunorimasaki clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT takanoriasakura clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT koichifukunaga clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT naotominematsu clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT makotoishii clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT keitamasuzawa clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT ichirokawada clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT tadashimanabe clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT masahirokondo clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT shotarochubachi clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT honamkoong clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT hidekiterai clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT junkokagyo clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT tetsuyashiomi clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT keikoohgino clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT soheinakayama clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT yusukesuzuki clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT yoheifunatsu clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT hidefumikoh clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT ryotakemura clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT fumimaroito clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT mizuhahashiguchi clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT takahirofukui clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife
AT junmiyata clusteranalysisoflongcovidinjapanandassociationofitstrajectoryofsymptomsandqualityoflife